Inicio・Lista de Acciones・Ocugen Inc

Ocugen Inc

Cerrado

1.32 -3.65

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.32

Máximo

1.37

Métricas clave
By Trading Economics
Ingresos	-5.7M -25M
Ventas	-45K 1.5M
BPA	-0.07
Margen de beneficios	-1,671.841
Empleados	116
EBITDA	-2.5M -20M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+648.18% upside

Dividendos
By Acuity
Próximas Ganancias	4 nov 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	45M 461M
Apertura anterior	4.97
Cierre anterior	1.32

Ocugen Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

28 ago 2026, 23:56 UTC

Shares of Astronics Corp were higher during after-market hours, despite earlier fluctuations. The stock remains near the lower end of its one-month trading range.

28 ago 2026, 23:56 UTC

Monro Inc shares are slightly higher in after-market hours, maintaining a position about 5% above the 20-day moving average. No specific news was identified.

28 ago 2026, 23:56 UTC

Williams-Sonoma Inc. shares are trading higher in after-market hours, recovering from earlier fluctuations amid rising interest rate hike expectations.

28 ago 2026, 23:56 UTC

Zillow Group Inc shares are lower in after-market trading. Broader market conditions reflect increased expectations for an interest rate hike.

28 ago 2026, 23:56 UTC

Sana Biotechnology Inc. shares advanced modestly higher in after-market trading, remaining near the upper end of their one-month range.

28 ago 2026, 23:56 UTC

News

nVent Electric PLC will acquire Maverick Power for $1.75 billion, with additional performance-based payments. Shares are higher during after-market hours following the announcement.

28 ago 2026, 23:56 UTC

Shoals Technologies Group Inc. shares are higher in after-market trading, rebounding from earlier session lows, though still below the 20-day moving average.

28 ago 2026, 23:56 UTC

Pool Corp shares are higher in after-market trading, though no specific news explains the movement. Broader market dynamics may be influencing trading activity.

28 ago 2026, 23:56 UTC

Amgen Inc shares are lower in after-market hours, continuing a trend of declines after four consecutive sessions of lower finishes. No specific news was identified.

28 ago 2026, 23:56 UTC

Archer-Daniels-Midland Co shares are higher in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

28 ago 2026, 23:56 UTC

CareDx Inc shares are higher in after-market hours, reflecting a generally strong performance backdrop amid rising market expectations for a potential interest rate hike.

28 ago 2026, 23:52 UTC

Brazil's Q2 GDP Growth Rate Release on September 1, 2026, Faces Mixed Expectations Amid Inflation and High Interest Rates Concerns.

28 ago 2026, 23:52 UTC

Market Anticipation Rises for Interest Rate Hike Following Fed Chair Warsh's Hawkish Remarks on Inflation at Jackson Hole Symposium

28 ago 2026, 23:52 UTC

South Africa's Balance of Trade Report on August 31, 2026, Expected to Reflect Continued Fluctuations Amidst Recent Surplus and Easing Inflation Pressures.

28 ago 2026, 23:51 UTC

Macro Event

Macro News

Ethereum is trading lower as hawkish remarks from Fed Chairman Warsh raise inflation concerns. The Michigan Consumer Sentiment index also reported a decline.

28 ago 2026, 23:51 UTC

Mid-America Apartment Communities shares are lower in after-market hours as rising interest rate expectations pressure investor sentiment and contribute to the stock's decline.

28 ago 2026, 23:51 UTC

Revolve Group Inc shares are higher in after-market trading, reflecting a notable rise since Friday's close amid increased market expectations for a rate hike.

28 ago 2026, 23:51 UTC

Constellation Energy shares higher in after-market trading, maintaining a steady upward trajectory near the upper end of its one-month range. No specific news identified.

28 ago 2026, 23:51 UTC

Starbucks Corp shares rose in after-market trading, supported by increased market expectations for a rate hike next month. The stock reached a high during this session.

28 ago 2026, 23:51 UTC

Global equity markets rise as Fed's Warsh signals potential interest rate hike amid persistent inflation concerns, while U.S. consumer sentiment dips and Canadian GDP growth falls short of expectations.

28 ago 2026, 23:51 UTC

US equity markets remain flat as investors react to hawkish signals from Fed Chair Warsh's Jackson Hole speech, raising interest rate hike expectations and impacting bond yields and tech stocks.

28 ago 2026, 23:51 UTC

Asia equity markets rise ahead of Fed Chair Warsh's hawkish speech, signaling potential interest rate hikes amid persistent inflation concerns.

28 ago 2026, 23:51 UTC

European equities rise as strong Euro Area sentiment data and hawkish Fed signals boost interest rate hike expectations amid mixed labor market and inflation concerns.

28 ago 2026, 23:51 UTC

Applied Industrial Technologies Inc shares rose in after-market trading, recovering from earlier losses amid rising market expectations for a rate hike next month.

28 ago 2026, 23:51 UTC

Vanguard Mortgage-Backed Securities ETF is trading higher after the market closed, despite some volatility and no specific news to explain the movement.

28 ago 2026, 23:51 UTC

Social Media

CACI shares are lower in after-market hours following a Supreme Court ruling that overturned a previous verdict related to the company's liability for torture at Abu Ghraib.

28 ago 2026, 23:51 UTC

N-Able Inc shares are lower in after-market hours, with no specific news identified. Increased market expectations for a rate hike may be influencing the decline.

28 ago 2026, 23:51 UTC

Citizens Financial Group Inc shares are lower in after-market hours, reflecting broader market trends amid rising expectations for a rate hike and higher Treasury yields.

28 ago 2026, 23:51 UTC

Tower Semiconductor Ltd is gaining in after-market trading, reflecting a notable uptick since Friday's close, despite three consecutive lower daily finishes.

28 ago 2026, 23:51 UTC

Autodesk Inc shares declined in after-market trading, reaching a low of -0.56%. No specific company news was identified for the movement.

Comparación entre iguales

Cambio de precio

Ocugen Inc previsión

Precio Objetivo

By TipRanks

648.18% repunte

Estimación a 12 Meses

Media 10.25 USD 648.18%

Máximo 12 USD

Mínimo 8 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Ocugen Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Ocugen Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.